One-size-fits-all approaches need to be phased out in favor of microtargeted communications and campaigns.
Pharma joined gaming and tech firms on the list of businesses that enjoyed positive results.
Execs from Pfizer, Sanofi and CVS Health shared company updates with the virtual throng.
In their presentations, BioNTech, J&J and Novavax execs offered glimpses of the road ahead.
A tiny team of three focuses on transparency as the vaccine is submitted for emergency use authorization.
Drug companies kicked off the new year by announcing price hikes.
The new company will sell both Mylan’s branded and generic drugs and Pfizer’s off-patent treatments, such as Viagra.
A standout Q2 performance by GSK’s meningitis shot helped offset genericization of off-patent asthma med Advair.
The Swiss drugmaker, which reported an otherwise upbeat second quarter, allocated a substantial reserve to settle bribery charges stemming from the suit.
A report from the IQVIA Institute for Human Data Science identified areas to watch through 2023.
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.